Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive function beyond three months of treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Collaborator: Janssen, LP
• Treatments: Antipsychotic Agents; Risperidone

Criteria

Inclusion Criteria:

• male or female between 18-40 years of age

• meet DSM-IV criteria for first-episode schizophreniform, schizophrenia or schizoaffective disorder

Exclusion Criteria:

• pregnant & breast-feeding women

• patients with known sensitivity to oral Risperdal